Search results
Jose L Merino
Research Area(s) / Expertise:
Job title: Director of the Arrhythmia– Electrophysiology Research Unit
Author
Author(s):
James L Januzzi
Added:
4 years ago
In this video, Prof James Januzzi (Harvard Medical School, MA, US) presents a comprehensive review of PROVE-HF - Interpreting potential mechanistic data related to the clinical benefit of ARNI therapy including imaging and biomarker data.
Filmed on site at ESC 2019 by Radcliffe Cardiology.
This interview is a component of a wider Radcliffe Education programme entitled,'Review of emerging ARNI…
View more
Author(s):
Carolyn Lam
,
Andrew JS Coats
Added:
4 years ago
In this video Prof Carolyn Lam (National Heart Centre Singapore, Singapore, SG) and Prof Andrew Coats (University of Warwick, Coventry, UK) discuss SGLT2 in HF.
Filmed on site at ESC 2019 by Radcliffe Cardiology.
This interview is a component of a wider Radcliffe Education programme entitled,'Current and emerging data on SGLT2 inhibitors in heart failure'. Certified accreditation of the full…
View more
Author(s):
Andrew JS Coats
,
Scott Solomon
Added:
4 years ago
In this video Prof Scott Solomon (Harvard Medical School, MA, US) and Prof Andrew Coats (University of Warwick, UK) discuss the Assessment of Real Life Care-Describing European Heart Failure Management (ARIADNE) registry which assessesManagement of Heart Failure with reduced Ejection Fraction in Europe
Filmed on site at ESC 2019 by Radcliffe Cardiology.
Videography: Mike Knight & Tom Green
…
View more
Author(s):
Andrew JS Coats
,
Scott Solomon
Added:
4 years ago
In this video Prof Scott Solomon (Harvard Medical School, MA, US) and Prof Andrew Coats (University of Warwick, UK) discuss theEffects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes (PROVE-HF) andEffect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction (EVALUATE-HF) studies and their…
View more
Author(s):
Jose L Merino
Added:
3 years ago
Quality is considered a strategic variable by most companies, public institutions and organisations in general. This is true to the extent that, for most companies, survival in the global market is considered to be directly related to their capacity to compete in terms of quality. Both public and private health services and professional healthcare workers in those services also have a…
View more
Author(s):
Akshay S Desai
Added:
4 years ago
In this video, Prof Akshay Desai (Harvard Medical School, MA, US) presents a comprehensive review of EVALUATE-HF.
Filmed on site at ESC 2019 by Radcliffe Cardiology.
Interviewer: Carrie Barclay
Videography: Mike Knight & Tom Green
This interview is a component of a wider Radcliffe Education programme entitled,'Review of emerging ARNI data in HFrEF'. Certified accreditation of the full…
View more
TRANSITION-CHF-In review
Author(s):
Rolf Wachter
Added:
4 years ago
Video
Author(s):
John JV McMurray
,
Mikhail Kosiborod
Added:
4 years ago
In this video Prof John McMurray (Glasgow University Hospital, Glasgow,UK) and Prof Mikhail Kosiborod (Saint Luke's Mid America Heart Institute, Kansas City, US) discuss the DAPA-HF trial.
This interview is a component of a wider Radcliffe Education programme entitled,'Current and emerging data on SGLT2 inhibitors in heart failure'. Certified accreditation of the full programme is pending…
View more
SGLT2 beyond diabetes
Author(s):
Lars H Lund
Added:
4 years ago
Video